ENXTBR:MITRAPharmaceuticals
Mithra Pharmaceuticals SA (EBR:MITRA): When Will It Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Mithra Pharmaceuticals...
ENXTBR:UCBPharmaceuticals
Public companies account for 37% of UCB SA's (EBR:UCB) ownership, while institutions account for 35%
Key Insights The considerable ownership by public companies in UCB indicates that they collectively have a greater say...
ENXTBR:UCBPharmaceuticals
Is UCB (EBR:UCB) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
ENXTBR:MITRAPharmaceuticals
Mithra Pharmaceuticals SA's (EBR:MITRA) market cap dropped €19m last week; Individual investors bore the brunt
Key Insights The considerable ownership by individual investors in Mithra Pharmaceuticals indicates that they...
ENXTBR:UCBPharmaceuticals
The past three years for UCB (EBR:UCB) investors has not been profitable
Many investors define successful investing as beating the market average over the long term. But in any portfolio...
ENXTBR:UCBPharmaceuticals
UCB SA's (EBR:UCB) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
UCB's (EBR:UCB) stock up by 6.6% over the past three months. However, the company's financials look a bit inconsistent...
ENXTBR:UCBPharmaceuticals
Are Investors Undervaluing UCB SA (EBR:UCB) By 48%?
Key Insights The projected fair value for UCB is €155 based on 2 Stage Free Cash Flow to Equity UCB is estimated to be...
ENXTBR:MITRAPharmaceuticals
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
You may think that with a price-to-sales (or "P/S") ratio of 2.2x Mithra Pharmaceuticals SA ( EBR:MITRA ) is a stock...
ENXTBR:UCBPharmaceuticals
Just Four Days Till UCB SA (EBR:UCB) Will Be Trading Ex-Dividend
It looks like UCB SA ( EBR:UCB ) is about to go ex-dividend in the next 4 days. The ex-dividend date is usually set to...
ENXTBR:UCBPharmaceuticals
UCB's (EBR:UCB) Upcoming Dividend Will Be Larger Than Last Year's
The board of UCB SA ( EBR:UCB ) has announced that it will be paying its dividend of €0.931 on the 3rd of May, an...
ENXTBR:HYLPharmaceuticals
Hyloris Pharmaceuticals Reports Full Year 2022 Earnings
Hyloris Pharmaceuticals ( EBR:HYL ) Full Year 2022 Results Key Financial Results Net loss: €10.8m (loss narrowed by...
ENXTBR:MITRAPharmaceuticals
Mithra Pharmaceuticals Reports Full Year 2022 Earnings
Mithra Pharmaceuticals ( EBR:MITRA ) Full Year 2022 Results Key Financial Results Revenue: €67.0m (up 196% from FY...
ENXTBR:UCBPharmaceuticals
UCB Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
UCB ( EBR:UCB ) Full Year 2022 Results Key Financial Results Revenue: €5.45b (down 5.7% from FY 2021). Net income...
ENXTBR:MITRAPharmaceuticals
Shareholders in Mithra Pharmaceuticals (EBR:MITRA) have lost 90%, as stock drops 12% this past week
As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So take a...
ENXTBR:HYLPharmaceuticals
Hyloris Pharmaceuticals SA's (EBR:HYL) Profit Outlook
Hyloris Pharmaceuticals SA ( EBR:HYL ) is possibly approaching a major achievement in its business, so we would like to...